Is COVID-19 less severe in CML patients than in those with other haematological cancers?

Simone Claudiani^{1

2}

Affiliations

¹ Department of Haematology, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, UK.
² Centre for Haematology, Department of Immunology and Inflammation, Hammersmith Campus, Imperial College London, London, UK.

Comment

Simone Claudiani. Br J Haematol. 2022 Feb.

. 2022 Feb;196(3):471-472.

doi: 10.1111/bjh.17927. Epub 2021 Oct 27.

Simone Claudiani^{1

2}

¹ Department of Haematology, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, UK.
² Centre for Haematology, Department of Immunology and Inflammation, Hammersmith Campus, Imperial College London, London, UK.

No abstract available

Conflict of interest statement

None.

COVID-19 infection in chronic myeloid leukaemia after one year of the pandemic in Italy. A Campus CML report.
Breccia M, Abruzzese E, Accurso V, Attolico I, Barulli S, Bergamaschi M, Binotto G, Bocchia M, Bonifacio M, Caocci G, Capodanno I, Castagnetti F, Cavazzini F, Crisà E, Crugnola M, Stella De Candia M, Elena C, Fava C, Galimberti S, Gozzini A, Gugliotta G, Intermesoli T, Iurlo A, La Barba G, Latagliata R, Leonetti Crescenzi S, Levato L, Loglisci G, Lucchesi A, Luciano L, Lunghi F, Luzi D, Malato A, Cristina Miggiano M, Pizzuti M, Pregno P, Rapezzi D, Rege-Cambrin G, Rosti G, Russo S, Sancetta R, Rita Scortechini A, Sorà F, Sportoletti P, Stagno F, Tafuri A, Tiribelli M, Foà R, Saglio G. Breccia M, et al. Br J Haematol. 2022 Feb;196(3):559-565. doi: 10.1111/bjh.17890. Epub 2021 Oct 11. Br J Haematol. 2022. PMID: 34636033 Free PMC article.

1. Tian J, Yuan X, Xiao J, Zhong Q, Yang C, Liu BO, et al. Clinical characteristics and risk factors associated with COVID‐19 disease severity in patients with cancer in Wuhan, China: a multicentre, retrospective, cohort study. Lancet Oncol. 2020;21(7):893–903. - PMC - PubMed
1. Lee LYW, Cazier J‐B, Starkey T, Briggs SEW, Arnold R, Bisht V, et al. COVID‐19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study. Lancet Oncol. 2020;21(10):1309–16. - PMC - PubMed
1. Fattizzo B, Giannotta JA, Sciumè M, Cattaneo D, Bucelli C, Fracchiolla NS, et al. Reply to "COVID‐19 in persons with haematological cancers": a focus on myeloid neoplasms and risk factors for mortality. Leukemia. 2020;34(7):1957–60. - PMC - PubMed
1. Regalado‐Artamendi I, Jiménez‐Ubieto A, Hernández‐Rivas JÁ, Navarro B, Núñez L, Alaez C, et al. Risk factors and mortality of COVID‐19 in patients with lymphoma: a multicenter study. Hemasphere. 2021;5(3):e538. - PMC - PubMed
1. Chari A, Samur MK, Martinez‐Lopez J, Cook G, Biran N, Yong K, et al. Clinical features associated with COVID‐19 outcome in multiple myeloma: first results from the International Myeloma Society data set. Blood. 2020;136(26):3033–40. - PMC - PubMed